Advances in Stem Cell Therapy for Type 2 Diabetes Mellitus

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis revealed enhanced glycemic control in patients with type 2 diabetes, suggesting stem cell therapy could improve outcomes.

Recent advances show stem cell therapy can reduce blood glucose levels and improve HbA1c in type 2 diabetes mellitus.
In early clinical trials, patients experienced insulin independence and better beta-cell survival due to stem cell treatments.
Innovative approaches such as 3D bioprinting and gene therapy are enhancing the potential of stem cell applications in treating T2DM.
Challenges remain in scalability, safety, and regulation for implementing stem cell therapies in clinical settings.

Bterrani et al. (2024) studied this question.

View Full Paper

Ask AI

Bookmark

Observational analysis revealed enhanced glycemic control in patients with type 2 diabetes, suggesting stem cell therapy could improve outcomes.